-
RNA-seq data from Non Small Cell Lung Cancer (NSCLC) samples
Study
EGAS00001004032
-
Tumor HTG EdgeSeq from metastatic castrate resistant prostate cancer
Study
EGAS00001004852
-
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer
Study
EGAS00001007430
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Finding structural variation and functional consequences from primary acute myeloid leukemia cells with complex karyotype (CK-AML) at the single-cell level
Study
EGAS00001007436
-
CUPiD, a cfDNA methylation-based tissue-of-origin classifier for Cancers of Unknown Primary
Study
EGAS00001007445
-
Somatic_mutation_and_clonal_evolution_in_the_human_testes___WES
Study
EGAS00001003023
-
Oesophageal_Adenocarcinoma_Organoids_Iso_Seq
Study
EGAS00001004051
-
BCL3-rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
Study
EGAS00001007465
-
Heterogeneous metabolic signatures are linked to cancer cell differentiation in colorectal cancer
Study
EGAS00001004064
-
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary with Neuroendocrine Differentiation
Study
EGAS00001003026
-
Genomic and transcriptomic landscape of aggressive thyroid cancer
Study
EGAS00001003540
-
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: new ROS1 fusion gene and PBX1 as prognostic marker
Study
EGAS00001007525
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Study
EGAS00001005549
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Whole exome sequencing data of germline and two independent primary leukemias of five patients
Study
EGAS00001001889
-
Whole exome sequencing on Pediatric MDS patients
Study
EGAS00001005432
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
Low-coverage whole-genome sequencing of cancer and healthy plasma circulating DNA
Study
EGAS00001007593
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__head___neck
Study
EGAS00001005450
-
Comprehensive pharmacogenomic characterization of gastric cancer
Study
EGAS00001004106
-
Human genomic and phenotypic synthetic data for the study of rare diseases
Study
EGAS00001005702
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___GI___TPS___WGS
Study
EGAS00001003089
-
Combination_Immune_Checkpoint_Inhibition_in_Australian_Rare_Cancers_WES
Study
EGAS00001005709